======= FAM58A ======= == Gene Information == * **Official Symbol**: CCNQ * **Official Name**: cyclin Q * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=92002|92002]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N1B3|Q8N1B3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FAM58A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FAM58A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300708|Open OMIM]] == Function Summary == * **Entrez Summary**: Mutations in this gene have been shown to cause an X-linked dominant STAR syndrome that typically manifests syndactyly, telecanthus and anogenital and renal malformations. The protein encoded by this gene contains a cyclin-box-fold domain which suggests it may have a role in controlling nuclear cell division cycles. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]. * **UniProt Summary**: Activating cyclin for the cyclin-associated kinase CDK10. {ECO:0000269|PubMed:18297069, ECO:0000269|PubMed:24218572}. No Pfam Domain information is available for this gene. |cyclin-dependent protein serine/threonine kinase regulator activity| |regulation of cyclin-dependent protein serine/threonine kinase activity| |regulation of cyclin-dependent protein kinase activity| |regulation of protein serine/threonine kinase activity| |regulation of protein kinase activity| |regulation of kinase activity| |regulation of transferase activity| |regulation of cell cycle| |regulation of protein phosphorylation| |regulation of phosphorylation| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-4.26| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-4.15| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-3.9| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-3.24| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-3.08| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-2.21| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-1.92| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-1.91| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.72| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|1.76| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.8| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|1.8| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.87| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|1.88| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.88| |[[:results:exp83|Trametinib 10μM R02 exp83]]|1.95| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|1.98| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2| |[[:results:exp264|Arsenate 40μM R06 exp264]]|2.05| |[[:results:exp532|TIC10 10μM R08 exp532]]|2.05| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|2.18| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|2.25| |[[:results:exp346|CoCl2 18μM R07 exp346]]|2.28| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.35| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|2.42| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.55| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.71| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|3.02| |[[:results:exp485|GSK626616 14μM R08 exp485]]|4.4| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|4.4| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|6.2| ^Gene^Correlation^ |[[:human genes:t:ttc14|TTC14]]|0.721| |[[:human genes:c:cdk10|CDK10]]|0.681| |[[:human genes:r:rprd1b|RPRD1B]]|0.528| |[[:human genes:c:ccnk|CCNK]]|0.502| Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ == Essentiality in NALM6 == * **Essentiality Rank**: 5279 * **Expression level (log2 read counts)**: 4.02 {{:chemogenomics:nalm6 dist.png?nolink |}}